Henry Schein | HSIC - Gross Profit On Sales

Stock Price
72.71
Daily Change
-0.01 -0.01%
Monthly
-8.14%
Yearly
1.21%
Q2 Forecast
71.26

Henry Schein reported $1.07B in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
Agilent USD 946M 44M Dec/2025
Align Technology USD 736.59M 53M Mar/2026
Bruker USD 379.8M 69.4M Mar/2026
Cardinal Health USD 2.5B 101M Mar/2026
Charles River Laboratories USD 279.32M 7.36M Mar/2026
Cigna USD 6.08B 50.37B Mar/2026
Concord Medical Services Hldg CNY -37.42M 26.25M Jun/2023
Cooper Companies USD 695.2M 44.4M Dec/2025
CVS Health USD 15.62B 2.06B Mar/2026
Danaher USD 3.59B 375M Mar/2026
Dentsply International USD 427M 16M Mar/2026
Encompass Health USD 1.48B 67.2M Dec/2025
Henry Schein USD 1.07B 7M Mar/2026
Idexx Laboratories USD 722.74M 64.62M Mar/2026
IQVIA Holdings USD 1.07B 52M Mar/2026
Laboratory Of America USD 1.01B 20.6M Mar/2026
McKesson USD 3.68B 143M Dec/2025
Mettler Toledo International USD 675.44M 65.98M Dec/2025
Owens Minor USD 272.05M 20.92M Dec/2025
Quest Diagnostics USD 906M 33M Mar/2026
Revvity USD 387.66M 34M Mar/2026
Stryker USD 3.81B 675M Mar/2026
Tenet Healthcare USD 4.52B 2.3B Dec/2025
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
Universal Health Services USD 4.06B 2.05B Dec/2025
Veradigm USD 83.44M 3.95M Sep/2022
Waters USD 542M 15.42M Mar/2026
Zimmer Biomet Holdings USD 1.27B 8.1M Dec/2025
Zoetis USD 1.62B 20M Mar/2026